The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study. (EMOACQ-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05988840
Recruitment Status : Not yet recruiting
First Posted : August 14, 2023
Last Update Posted : August 15, 2023
Sponsor:
Information provided by (Responsible Party):
Emobot

Brief Summary:

The worldwide prevalence of anxiety and depression increased massively during the pandemic, with a 25% rise in the number of patients suffering from psychological distress. Psychiatrists, and even more so general practitioners, need measurement tools that enable them to remotely monitor their patients' psychological state of health, and to be automatically alerted in the event of a break in behavior.

In this study, the investigators propose to collect clinical data along with longitudinal measurement of patients' emotions. Emobot proposes to analyze the evolution of mood disorders over time by passively studying people's emotional behavior. The aim of EMOACQ-1 is to acquire knowledge and produce a quantitative link between emotional expression and mood disorders, ultimately facilitating the understanding and management of these disorders.

Through this study, could be developed a technological solution to support healthcare professionals and patients in psychiatry, a field known as the "poor relation of medicine" and lacking in resources. Such a solution would enable better understanding, disorders remote & continuous monitoring and, ultimately, better treatment of these disorders.

The investigators will process the data by carrying out a number of analyses, including descriptive, comparative and correlation studies of the data from the self-questionnaire results and the emotional signals captured by the devices.

Finally, the aim will be to predict questionnaire scores from the emotional signals produced.


Condition or disease Intervention/treatment
Anxiety Disorders Major Depressive Disorder Other: Acquisition and analysis of relationships between Longitudinal Emotional Signals produced by a software and Self-questionnaires.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study.
Estimated Study Start Date : October 17, 2023
Estimated Primary Completion Date : August 17, 2024
Estimated Study Completion Date : October 17, 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Group/Cohort Intervention/treatment
The hardware group (on-board camera)
A physical device equipped with a camera and embedding the acquisition/monitoring software. Positioned in the living space, it will be possible to capture the facial expressions of the person in ecology, for example when watching a TV program or reading.
Other: Acquisition and analysis of relationships between Longitudinal Emotional Signals produced by a software and Self-questionnaires.
Using the tool developed by Emobot, EMOACQ-1 is a study that passively and non-interventionaly collects data by capturing patients' facial expressions throughout the day, and then measures the correlation between emotional signals and the results of measurement questionnaires used in psychiatry.

The software-only group (running on a PC or tablet and using the available webcam)
Software running on a computer, connected to the computer's camera (webcam). If the person is teleworking on a PC, it is expected that images will be captured during videoconferencing-type interactions.
Other: Acquisition and analysis of relationships between Longitudinal Emotional Signals produced by a software and Self-questionnaires.
Using the tool developed by Emobot, EMOACQ-1 is a study that passively and non-interventionaly collects data by capturing patients' facial expressions throughout the day, and then measures the correlation between emotional signals and the results of measurement questionnaires used in psychiatry.




Primary Outcome Measures :
  1. Repeated measurements Correlations between emotional signals and studied disorders standardized tests. [ Time Frame: 10 months ]
    Repeated measurements Correlations between emotional signals and studied disorders standardized tests.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The first cohort of 20 participants will be provided with the 20 measuring embedded device, we will be able to collect specific data at targeted times and for specific activities.

The second cohort formed with the remaining participants will receive the software on their personal computer, enabling us to capture more general data and analyze behavior patterns in less controlled contexts.

Criteria

Inclusion Criteria:

  • Persons over the age of 18 who volunteer to take part in research
  • Must have access to a computer with an Internet connection,
  • Written comprehension of French.

Exclusion Criteria:

  • N/A

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05988840


Contacts
Layout table for location contacts
Contact: Tanel Petelot +33 51 44 26 67 ext +33 tanel.petelot@emobot.fr

Sponsors and Collaborators
Emobot
Additional Information:
Layout table for additonal information
Responsible Party: Emobot
ClinicalTrials.gov Identifier: NCT05988840    
Other Study ID Numbers: 2023-A01589-36
First Posted: August 14, 2023    Key Record Dates
Last Update Posted: August 15, 2023
Last Verified: August 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Depressive Disorder
Depressive Disorder, Major
Mental Disorders
Mood Disorders